Recombinant Human COL17A1 Protein，His

COL17A1, also known as collagen type XVII alpha 1, is a critical component of the extracellular matrix and a key player in cell adhesion and skin integrity. This protein is primarily expressed in the basal layer of the epidermis and is associated with the hemidesmosomes that anchor the epidermis to the underlying basement membrane. Mutations in the COL17A1 gene can lead to various skin disorders, including epidermolysis bullosa, a condition characterized by extreme fragility of the skin resulting in blister formation upon minimal friction. Due to its importance in skin biology and pathology, COL17A1 has garnered significant research interest, particularly in understanding its role in skin health, disease mechanisms, and potential therapeutic targets. Recombinant COL17A1 proteins have been developed to investigate their structure-function relationships, study protein interactions, and explore their potential as biomarkers or therapeutic agents in dermatological diseases. Furthermore, understanding the molecular dynamics of COL17A1 may contribute to advancements in regenerative medicine and tissue engineering, offering insights into wound healing and skin repair processes. Overall, the study of recombinant COL17A1 proteins is pivotal for elucidating the underlying mechanisms of skin integrity and disease, with significant implications for developing innovative treatments for skin-related conditions.